Skip to main content

Giant Virus Has CRISPR-like Immune Defense

The genome of a mimivirus strain resistant to a virophage has repeated phage sequences alongside nuclease- and helicase-coding sections.

Written byKerry Grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00

WIKMEDIA, PLOS BIOL, 7:e1000092, 2009A giant virus known as mimivirus possesses an immune program similar to CRISPR, a defense system evolved by bacteria and archaea and now adapted by scientists for genome editing, researchers reported in Nature this week (February 29). Like CRISPR, the viral version (dubbed MIMIVIRE) includes a stretch of host genome containing repeated sequences matching a pathogen’s along with genes that can destroy the invader’s genome.

The precise method of immunity still has to be deciphered, Francisco Mójica, a microbiologist at the University of Alicante in Spain, told Nature News. “It will certainly be of great interest to identify the mechanism involved in MIMIVIRE immunity,” he said, adding that he suspects it works differently from CRISPR.

Didier Raoult, a microbiologist at Aix-Marseille University in France, and colleagues had previously discovered that a virophage, called Zamilon, could infect mimivirus—but only two lineages (B and C). A third lineage of mimivirus (A) was resistant to the virophage.

Supposing the resistance might have roots in a CRISPR-like mechanism, Raoult’s team sequenced genomes from the three giant-virus lineages, and found a 28-nucleotide stretch of DNA in lineage A identical to a sequence in Zamilon. Part ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile

Related Topics

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Improving rAAV Production for Viral Vector Manufacturing

Improving rAAV Production for Viral Vector Manufacturing

cytiva logo
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems
Optimizing NGS Library Preparation for Reliable Sequencing Data

Optimizing NGS Library Preparation for Reliable Sequencing Data

Covaris

Products

Sino Biological Logo

Sino Biological Launches European Newsletter Campaign with Exclusive Welcome Gifts

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo